OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
Geonhee Han, Dahye Noh, Hokyung Lee, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114973-114973
Open Access | Times Cited: 29
Geonhee Han, Dahye Noh, Hokyung Lee, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114973-114973
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
A panoramic perspective of recent progress in 2D and 3D covalent organic frameworks for drug delivery
Fariba Mehvari, Vahid Ramezanzade, Parvin Asadi, et al.
Aggregate (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 16
Fariba Mehvari, Vahid Ramezanzade, Parvin Asadi, et al.
Aggregate (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 16
Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery
Lingxiao Xu, Z. Shao, Xia Fang, et al.
Exploration (2024)
Open Access | Times Cited: 10
Lingxiao Xu, Z. Shao, Xia Fang, et al.
Exploration (2024)
Open Access | Times Cited: 10
The mRNA vaccine, a swift warhead against a moving infectious disease target
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
Sheema Mir, Mohammad A. Mir
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 336-348
Open Access | Times Cited: 8
A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism
Jingxin Li, Xiaolin Wang, Liang Shi, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 17
Jingxin Li, Xiaolin Wang, Liang Shi, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 17
Membrane-coated protein nanoparticles for mRNA delivery
Xinxi Cai, Aftab Ullah, Rui Qian, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105427-105427
Closed Access | Times Cited: 6
Xinxi Cai, Aftab Ullah, Rui Qian, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105427-105427
Closed Access | Times Cited: 6
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
Pei Huang, Hongzhang Deng, Changrong Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 16
Pei Huang, Hongzhang Deng, Changrong Wang, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 16
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 5
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (English Edition) (2024) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 5
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Menghao Yin, Hanruo Sun, Yanan Li, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 5
Menghao Yin, Hanruo Sun, Yanan Li, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 5
RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Nanoparticles for mRNA-based cancer immunotherapy
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
Advances in developing novel therapeutics, strategies, approaches, and use of emerging techniques
Prasann Kumar
Elsevier eBooks (2025), pp. 291-318
Closed Access
Prasann Kumar
Elsevier eBooks (2025), pp. 291-318
Closed Access
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy
Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, et al.
Advances in immunology (2025)
Closed Access
Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, et al.
Advances in immunology (2025)
Closed Access
Amplifying the Antitumor Effect of STING Agonist MSA-2 by Phospholipid Nanoparticles Delivering STING mRNA and Copper-Modified MSA-2 Combination
Peng Zhou, Mo Wang, Tian He, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Peng Zhou, Mo Wang, Tian He, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
A Review on the Stability Challenges of Advanced Biologic Therapeutics
Sruthi Sarvepalli, Shashank Reddy Pasika, Vinod Verma, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 550-550
Open Access
Sruthi Sarvepalli, Shashank Reddy Pasika, Vinod Verma, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 550-550
Open Access
Development of polypeptide-based materials toward messenger RNA delivery
Bowen Zhao, Xiao Zhang, Molly S. Bickle, et al.
Nanoscale (2023) Vol. 16, Iss. 5, pp. 2250-2264
Closed Access | Times Cited: 10
Bowen Zhao, Xiao Zhang, Molly S. Bickle, et al.
Nanoscale (2023) Vol. 16, Iss. 5, pp. 2250-2264
Closed Access | Times Cited: 10
mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 8
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 8
Advances in Nanomaterials for Drug Delivery
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2023), pp. 22-85
Closed Access | Times Cited: 7
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2023), pp. 22-85
Closed Access | Times Cited: 7
Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier
Sarah Nasr, Pascal Paul, Brigitta Loretz, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 12, pp. 3339-3353
Closed Access | Times Cited: 2
Sarah Nasr, Pascal Paul, Brigitta Loretz, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 12, pp. 3339-3353
Closed Access | Times Cited: 2
Recent progress in gene therapy for familial hypercholesterolemia treatment
Yaxin Luo, Yaofeng Hou, Wenwen Zhao, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110641-110641
Open Access | Times Cited: 2
Yaxin Luo, Yaofeng Hou, Wenwen Zhao, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110641-110641
Open Access | Times Cited: 2
Advances in targeted delivery of mRNA into immune cells for enhanced cancer therapy
Linzhuo Huang, Zhiquan Huang, Yuxuan Zhang, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5528-5550
Open Access | Times Cited: 2
Linzhuo Huang, Zhiquan Huang, Yuxuan Zhang, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5528-5550
Open Access | Times Cited: 2
On-demand reprogramming of immunosuppressive microenvironment in tumor tissue via multi-regulation of carcinogenic microRNAs and RNAs dependent photothermal-immunotherapy using engineered gold nanoparticles for malignant tumor treatment
Li Chen, Wenjun Tang, Jie Liu, et al.
Biomaterials (2024) Vol. 315, pp. 122956-122956
Closed Access | Times Cited: 2
Li Chen, Wenjun Tang, Jie Liu, et al.
Biomaterials (2024) Vol. 315, pp. 122956-122956
Closed Access | Times Cited: 2
Recent advancements in cancer vaccines: A systematic review
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (2023) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 4
Stuti Srivastava, Devendra Singh, Sunil Kumar Verma, et al.
Vacunas (2023) Vol. 25, Iss. 1, pp. 97-108
Closed Access | Times Cited: 4
Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses
Alexandro Guterres, Paulo Niemeyer Filho, Vivaldo Moura‐Neto
Vaccines (2024) Vol. 12, Iss. 1, pp. 61-61
Open Access | Times Cited: 1
Alexandro Guterres, Paulo Niemeyer Filho, Vivaldo Moura‐Neto
Vaccines (2024) Vol. 12, Iss. 1, pp. 61-61
Open Access | Times Cited: 1
